CNRegulatory approval requirednoindex
GeraClinic in China
GeraClinic is blocked from public launch claims in China until regulatory, legal, and local partner approval gates pass.
Rollout tier
global-maintain
Content depth
waitlist-brief
City focus
Beijing
Gap score
12
Readiness score
0
Payment readiness
research-required
Proof Gate
Regulatory and local partner approval required before public indexing or conversion CTAs.
Legal review is required. Current status: required.
Country FAQ
Is GeraClinic fully available in China?
GeraClinic is blocked from public launch claims in China until regulatory, legal, and local partner approval gates pass.
What needs to happen before scale in China?
Regulatory and local partner approval required before public indexing or conversion CTAs.
Why might this page be noindex?
This page is intentionally kept out of search indexing until local proof, legal review, payment readiness, or partner gates pass.
Evidence
- ceo/strategy/market-gap-rollout-2026-04-24.md
- config/gtm/lean-market-gap-rollout-2026.json